Intuitive Surgical (ISRG) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Intuitive Surgical

NasdaqGS•Healthcare•Medical Instruments & Supplies

$383.54+1.25(<0.01%)After hours

Market Cap

$139.21B

P/E

44.4x

P/S

12.6x

P/B

7.6x

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

How this company scores

ExcellentMetricSide Score: 88/100

Strongest: Profitability (25/25); weakest: Balance Sheet & Red Flags (15/25).

Profitability25/25

Growth25/25

Balance Sheet & Red Flags15/25

Cash & Earnings Quality23/25

Strengths

Growing revenueRising free cash flowStrong marginsHigh ROE

No red flags in the last 8 quarters.

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 44.4x5y range 44.4x – 83.4x

Currently below its 20-quarter median.

P/S · 12.6x5y range 11.0x – 22.7x

Currently below its 20-quarter median.

P/B · 7.6x5y range 5.8x – 11.4x

Price & Volume

Market Cap $139.21B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $11.03B
Q. Revenue: $2.89B
TTM EBITDA: $4.17B
TTM Op. Income: $3.45B
Q. Op. Income: $971.90M
TTM Net Income: $3.14B
Q. Net Income: $818.10M
EPS: $2.31
Shares Out.: $354.10M

$11.03B in TTM revenue grew 20.7% YoY, reaching $2.89B last quarter. TTM EBITDA of $4.17B and TTM operating income of $3.45B show growth is flowing through to the bottom line. TTM net income of $3.14B means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 67.8%
EBITDA Margin: 41.1%
Op. Margin: 33.6%
Net Margin: 28.3%

Op. margin of 33.6% is up 3.1% YoY — cost efficiency is improving. Net margin at 28.3% and gross margin of 67.8% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has risen for 2 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 44.4x
P/S Ratio: 12.6x
P/B Ratio: 7.6x

At 44.4x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 12.6x and P/B of 7.6x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Across the last 8 quarters, P/E has fallen for 2 consecutive quarters — an improving trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $20.88B
Cash: $2.76B
Long-Term Debt: N/A
Book Value: $18.30B
D/E Ratio: N/A
Debt/EBITDA: 0.0

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $1.06B
TTM Free Cash Flow: $3.22B
FCF Margin: 29.2%
FCF / Net Income: 1.0

TTM FCF of $3.22B on $1.06B in operating cash flow. The FCF / Net Income ratio of 1.0x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has risen for 7 consecutive quarters — an improving trend.